Dear Colleague,
I read a recent study showed that there was essentially no increased risk associated with amniocentesis and CVS (Wulff CB, et al. Ultrasound Obstet Gynecol. 2016;47:38-44). Should we be using this latest assessment to counsel patients?
The purpose of this website and topics discussed upon it is to promote discussion about medical and scientific issues in the field of prenatal genetic diagnosis and reproductive health care. The information on this website, including but not limited to text, graphics, images, and other materials is for informational purposes only. It is not intended for the diagnosis or treatment of patients. It is not intended to substitute for professional medical advice, diagnosis or treatment.
